FLRY3 Stock Overview
Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Fleury S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$14.66 |
| 52 Week High | R$18.96 |
| 52 Week Low | R$13.46 |
| Beta | 0.59 |
| 1 Month Change | -3.17% |
| 3 Month Change | -11.10% |
| 1 Year Change | 6.01% |
| 3 Year Change | -39.75% |
| 5 Year Change | -25.42% |
| Change since IPO | 68.69% |
Recent News & Updates
The Price Is Right For Fleury S.A. (BVMF:FLRY3)
Apr 16
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance
Mar 14Recent updates
The Price Is Right For Fleury S.A. (BVMF:FLRY3)
Apr 16Concerns Surrounding Fleury's (BVMF:FLRY3) Performance
Mar 14Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)
Jan 05Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet
Oct 05Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Jun 27We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt
Feb 25At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Sep 26Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Sep 08Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger
Jul 01When Should You Buy Fleury S.A. (BVMF:FLRY3)?
Jun 10Is Fleury (BVMF:FLRY3) Using Too Much Debt?
Apr 10Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing
Mar 24At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Feb 08Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)
Dec 08Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly
Nov 05Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?
Oct 21Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital
Aug 24Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly
Jul 31Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?
Jul 07Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Apr 30Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue
Apr 12At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Mar 29Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)
Mar 16Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend
Mar 01Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?
Feb 15Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return
Feb 02
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date
Jan 03Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?
Dec 28Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?
Dec 12Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE
Nov 29Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult
Aug 30Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield
Aug 18Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?
Aug 03Could The Fleury S.A. (BVMF:FLRY3) Ownership Structure Tell Us Something Useful?
Jul 22Is Now The Time To Look At Buying Fleury S.A. (BVMF:FLRY3)?
Jul 10Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Jun 25Shareholder Returns
| FLRY3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 4.4% | 1.8% | -0.2% |
| 1Y | 6.0% | 1.8% | 13.7% |
Return vs Industry: FLRY3 exceeded the BR Healthcare industry which returned 3.9% over the past year.
Return vs Market: FLRY3 underperformed the BR Market which returned 13.9% over the past year.
Price Volatility
| FLRY3 volatility | |
|---|---|
| FLRY3 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.8% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: FLRY3 has not had significant price volatility in the past 3 months.
Volatility Over Time: FLRY3's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1926 | 27,300 | Jeane Tsutsui | ri.fleury.com.br |
Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging services.
Fleury S.A. Fundamentals Summary
| FLRY3 fundamental statistics | |
|---|---|
| Market cap | R$7.99b |
| Earnings (TTM) | R$423.76m |
| Revenue (TTM) | R$6.47b |
18.9x
P/E Ratio1.2x
P/S RatioIs FLRY3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FLRY3 income statement (TTM) | |
|---|---|
| Revenue | R$6.47b |
| Cost of Revenue | R$4.73b |
| Gross Profit | R$1.74b |
| Other Expenses | R$1.32b |
| Earnings | R$423.76m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 26.89% |
| Net Profit Margin | 6.55% |
| Debt/Equity Ratio | 55.0% |
How did FLRY3 perform over the long term?
See historical performance and comparison